PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
22-Mar-2022 Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute Biocomposites
22-Mar-2022 FILTHY PUBLIC TOUCHSCREENS TO BE SELF-CLEANING WITH VIRUS-KILLING COATING CodiKoat
22-Mar-2022 Coulter Partners places new Chief Scientific and Chief People Officers at Totus Medicines, supporting the drug discovery company’s senior leadership expansion Totus Medicines
22-Mar-2022 AACR 2022: Tollys releases new preclinical data demonstrating lifelong potent anti-tumor immunity of TL-532 Andrew Lloyd Associates
22-Mar-2022 CD Bioparticles Launches Heparins for Drug Delivery Research CD Bioparticles
22-Mar-2022 CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles CD Bioparticles
22-Mar-2022 Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens Creative Diagnostics
21-Mar-2022 CD Genomics: Ultralow Input RNA-Seq Service Now Available by Its RNA Solutions Platform CD Genomics
21-Mar-2022 CD Genomics MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development CD Genomics
18-Mar-2022 CD Formulation Launches Tailored Solutions for Increased Bioavailability Excipients CD Formulation
18-Mar-2022 Alfa Chemistry Launches API Research & Development Platform for the Pharmaceutical Industry Alfa Chemistry
17-Mar-2022 PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic PureTech
17-Mar-2022 Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme Oppilotech Ltd
17-Mar-2022 Leucid Bio Chief Scientific Officer John Maher publishes new research on pCAR technology Leucid Bio
17-Mar-2022 Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticals Precirix NV
17-Mar-2022 Tiziana Announces Availability of March 14 KOL Event Replay Tiziana Life Sciences
16-Mar-2022 Glooko acquiert DIABNEXT® pour élargir son offre dans le diabète en France Andrew Lloyd Associates
16-Mar-2022 Oppilotech and Evariste Technologies Announce Partnership to Develop First-in-Class Antibacterial Programme Oppilotech
15-Mar-2022 RNA Therapeutics Company SiSaf to Present at Upcoming Conferences SiSaf
15-Mar-2022 Etcembly Appoints Scott Cuthill as Chief Business Officer Etcembly